Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease

Aliment Pharmacol Ther. 2018 May;47(10):1422-1423. doi: 10.1111/apt.14603.

Authors

P Pavlidis¹, J Graham², S Gulati¹, P Dubois¹, M Heneghan², D Joshi², B Hayee¹

Affiliations

¹ Department of Gastroenterology, King's College Hospital, London, UK.
² Institute of Liver Studies, King's College Hospital, London, UK.

PMID: 29676010
DOI: 10.1111/apt.14603

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Cholangitis, Sclerosing*
Humans
Inflammatory Bowel Diseases*
Liver Diseases*

Substances

Antibodies, Monoclonal, Humanized
vedolizumab